Stockscreener 앱 받기
87.89
5.02%
-4.65
시장 영업 전:
87.89
전일 마감가:
$92.54
열려 있는:
$91.81
하루 거래량:
457.26K
Relative Volume:
1.37
시가총액:
$1.48B
수익:
$5.82B
순이익/손실:
$-373.54M
주가수익비율:
-3.8983
EPS:
-22.546
순현금흐름:
$-87.01M
1주 성능:
-6.29%
1개월 성능:
-3.68%
6개월 성능:
+496.57%
1년 성능:
+174.66%
1일 변동 폭
$82.61
$92.05
1주일 범위
$82.61
$99.19
52주 변동 폭
$7.48
$133.04
애질론 헬스 Stock (AGL) Company Profile
명칭
Agilon Health Inc
전화
562-256-3800
주소
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, EHC, DVA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
87.89 | 1.56B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
414.45 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
265.91 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.74 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
120.21 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
176.01 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
애질론 헬스 Stock (AGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-25 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-04-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-01-10 | 개시 | Needham | Hold |
| 2024-12-16 | 개시 | Macquarie | Neutral |
| 2024-12-11 | 개시 | Bernstein | Mkt Perform |
| 2024-11-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-04-22 | 개시 | Citigroup | Neutral |
| 2024-03-06 | 개시 | Barclays | Underweight |
| 2024-02-26 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-02-26 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-05 | 다운그레이드 | Truist | Buy → Hold |
| 2023-12-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-11-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-10-20 | 개시 | The Benchmark Company | Buy |
| 2023-06-13 | 개시 | Evercore ISI | In-line |
| 2022-12-09 | 개시 | Stifel | Buy |
| 2022-09-14 | 개시 | RBC Capital Mkts | Outperform |
| 2022-09-12 | 개시 | Goldman | Buy |
| 2022-09-07 | 재개 | Truist | Buy |
| 2022-06-24 | 개시 | BTIG Research | Neutral |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-10-20 | 개시 | Jefferies | Buy |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-05-11 | 개시 | William Blair | Outperform |
| 2021-05-10 | 개시 | BofA Securities | Buy |
| 2021-05-10 | 개시 | Deutsche Bank | Buy |
| 2021-05-10 | 개시 | Goldman | Buy |
| 2021-05-10 | 개시 | JP Morgan | Overweight |
| 2021-05-10 | 개시 | Truist | Buy |
| 2021-05-10 | 개시 | Wells Fargo | Overweight |
| 2021-05-10 | 개시 | Wolfe Research | Outperform |
모두보기
애질론 헬스 주식(AGL)의 최신 뉴스
Is Agilon Health Inc (AGL) Overvalued After 4.2% Rally? GF Value - GuruFocus
agilon health to Participate in Upcoming Conferences - Yahoo Finance
Agilon Health (NYSE:AGL) Trading Up 5.4%Here's Why - MarketBeat
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
AQR Capital Management Trims Agilon Health (AGL) Stake Amid Stoc - GuruFocus
agilon health (AGL) insider’s 17-share move is just tax withholding - Stock Titan
Agilon Health (AGL) Q2 2026 Earnings Call Transcript - AOL.com
Agilon Health (AGL) Institutional Ownership 2026 $AGL - MarketBeat
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
Agilon Health (NYSE:AGL) Trading 8.5% HigherHere's What Happened - MarketBeat
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
AGL|agilon health inc|Price:92.730|Chg%:-0.910 - TradingKey
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call - Yahoo Finance
Agilon Health (NYSE:AGL) Valuation Debate Grows After Guidance - Kalkine Media
Why Is AGL Stock Rising Today? - Stocktwits
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A - Stock Titan
Is Agilon Health Inc (AGL) a Bargain After 10.7% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Group (AGL) discloses 3.9% beneficial stake in agilon health - Stock Titan
Citigroup Upgrades Agilon Health to Neutral From Sell, Adjusts Price Target to $115 From $105 - marketscreener.com
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $115 - Moomoo
AGILON HEALTH, INC. : CITIGROUP RAISES TO NEUTRAL FROM SELL; RAISES TARGET PRICE TO $115 FROM $105 - Bitget
Agilon Health (AGL) Short Interest & Short Float | Updated Aug 2026 $AGL - marketbeat.com
Citi Upgrades Agilon Health(AGL.US) to Hold Rating, Raises Target Price to $115 - Moomoo
Weekly Recap: Cash, debt & guidance and CHF rollout, clinical expansion - TradingView
Agilon Health Earnings Call Signals Profitable Turnaround - The Globe and Mail
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $95 - Moomoo
Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable? - Yahoo Finance
agilon health: The Q2 Inflection Is Real (NYSE:AGL) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), Qiagen (QGEN) and Coherus Biosciences (CHRS) - The Globe and Mail
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $140 - Moomoo
Baird Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $116 - Moomoo
Evercore Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $125 - Moomoo
agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside - TradingView
Agilon Health (NYSE:AGL) Trading Down 9.9%What's Next? - MarketBeat
agilon health (AGL) Is Up 16.4% After Q2 Return To Profitability And Raised 2026 Outlook - simplywall.st
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $125 - Moomoo
Agilon Health Q2 Earnings Call Highlights - TradingView
AGILON HEALTH, INC. : BENCHMARK RAISES TARGET PRICE TO $140 FROM $95 - Moomoo
Earnings call transcript: Agilon Health tops Q2 2026 estimates and lifts outlook - Investing.com
Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
agilon health, inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Agilon Health (NYSE:AGL) Releases Earnings Results, Beats Estimates By $0.92 EPS - MarketBeat
Agilon: Q2 Earnings Snapshot - Barchart.com
Agilon Health tops Q2 estimates, raises 2026 guidance; Shares gain 3% - Investing.com South Africa
AGL Stock Jumps As Wells Fargo Doubles Price Target - StocksToTrade
(AGL) agilon health, inc. Expects Q3 Revenue Range $1.45B$1.48B - marketscreener.com
agilon health, inc. 2026: Revenue $1.49B, EPS $1.04— 10-Q Summary - TradingView
애질론 헬스 (AGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
애질론 헬스 주식 (AGL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wulf John William | Director |
Nov 12 '25 |
Buy |
0.63 |
81,000 |
50,941 |
365,857 |
0.41%
1.03%
자본화:
|
볼륨(24시간):